RxDoctor Payments Data

Paul Nghiem

Dermatology · Seattle, WANPI 1407932205

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $21,124 of the $32,215 with a category attached, or 65.6%. EMD Serono, Inc. accounts for 68.8% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $18,604, 5.5 times the $3,382 reported in 2019. Among dermatology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,215in general payments, 2019–2025

Across 20 payments — averaging $1610.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$22K
  • Almirall LLC$7K
  • Pfizer$3K
  • Sanofi$317
  • E.r. Squibb & Sons, L.L.C.$30
$2,409in research payments, 2019–2025

Across 1 payment — averaging $2408.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$2K

What the payments were for

  • Consulting fees$10,42432%
  • Speaking & faculty fees$21,12466%
  • Travel & lodging$4261%
  • Food & beverage$2421%

General payments by program year

19
20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Serono, Inc.11$22,158
Almirall LLC4$7,190
Pfizer1$2,520
Sanofi3$317
E.r. Squibb & Sons, L.L.C.1$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,215 in reported general payments places this provider in the 95th percentile of 323 dermatology providers in Washington.

See all dermatology providers in Washington

Medicare billing

Part B allowed, 2024
$31,098
Medicare patients
124
Services billed
361

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →